Steven Yatomi-Clarke
Directeur Général chez PRESCIENT THERAPEUTICS LIMITED
Fortune : 378 056 $ au 30/04/2024
Profil
Steven Yatomi-Clarke is currently the Chief Executive Officer, MD & Executive Director at Prescient Therapeutics Ltd.
He started this position in 2016.
Previously, he worked as the Director-Corporate Finance at Patersons Securities Ltd.
He has an undergraduate degree from the University of Melbourne.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
01/05/2023 | 11 195 017 ( 1,39% ) | 378 056 $ | 30/04/2024 |
Postes actifs de Steven Yatomi-Clarke
Sociétés | Poste | Début |
---|---|---|
PRESCIENT THERAPEUTICS LIMITED | Directeur Général | 15/02/2016 |
Anciens postes connus de Steven Yatomi-Clarke
Sociétés | Poste | Fin |
---|---|---|
Patersons Securities Ltd.
Patersons Securities Ltd. Investment Banks/BrokersFinance Patersons Securities Ltd. is a brokerage firm that provides brokerage services. The company was founded in 1903 and is based in Perth, Australia. Patersons Securities was acquired by Canaccord Genuity (Australia) Ltd. on October 21, 2019 for $17.42 million. | Corporate Officer/Principal | - |
Formation de Steven Yatomi-Clarke
University of Melbourne | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
PRESCIENT THERAPEUTICS LIMITED | Health Technology |
Entreprise privées | 1 |
---|---|
Patersons Securities Ltd.
Patersons Securities Ltd. Investment Banks/BrokersFinance Patersons Securities Ltd. is a brokerage firm that provides brokerage services. The company was founded in 1903 and is based in Perth, Australia. Patersons Securities was acquired by Canaccord Genuity (Australia) Ltd. on October 21, 2019 for $17.42 million. | Finance |